Wall Street Journal: Venture Capitalists Back Biotech Push to Combat Aging
Dec. 3, 2020 - It is early days for antiaging drug research, and even proponents acknowledge the field will face setbacks. But a growing understanding of the biological processes of aging is yielding insights into potential new ways of treating patients today—and prompting some entrepreneurs to imagine a future in which medications could be taken by healthy people to forestall a range of aging-related illnesses.